臺大醫院;臺大醫院-腫瘤醫學部;臺大醫學院-腫瘤醫學研究所;Zhu, A.A.ZhuKnox, J.J.KnoxKudo, M.M.KudoChan, S.S.ChanFinn, R.R.FinnSiegel, A.A.SiegelMa, J.J.MaWatson, P. A.P. A.WatsonCheng, A-L.A-L.Cheng鄭安理2017-06-272018-07-092017-06-272018-07-092016http://ntur.lib.ntu.edu.tw//handle/246246/280180[SDGs]SDG3Pembrolizumab in patients with previously treated advanced hepatocellular carcinoma: Phase 2 KEYNOTE-224 study10.1093/annonc/mdw371.108